Andrew G. Bosanquet - Concepedia

Author

Andrew G. Bosanquet

Also Known As

A G Bosanquet, A. G. Bosanquet, A.G. Bosanquet, ANDREW G. BOSANQUET, Andrew G Bosanquet, Andrew G. Bosanquet, AndrewG. Bosanquet

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Royal United Hospital University of Bath Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin Royal Marsden Hospital

About

Andrew G. Bosanquet is an author at Royal United Hospital specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	752
2	Health Sciences	4	4	317
3	Cell Biology	3	3	58
4	Chemistry	2	2	30
5	Engineering	1	1	14

Andrew G. Bosanquet

Publications

Citations

H-Index

Page 1

	Year	Citations
Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy Isrid Sturm, Andrew G. Bosanquet, Sandra Hermann, Cell Death and Differentiation B-cll OccursHealth SciencesMedicinePrior Dna-damaging ChemotherapyPharmacology	2003	143
High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities Patrick Thornton, Estella Matutes, Andrew G. Bosanquet, Annals of Hematology OncologyPathologyHigh Dose MethylprednisoloneCll PatientsImmune Checkpoint Inhibitor	2003	102
Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma Andrew G. Bosanquet, Edward D. Gilby European Journal of Cancer and Clinical Oncology Hematological MalignancyOncologyMedicineMalignant Blood DisorderHematology	1982	85
Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay Andrew G. Bosanquet The Lancet Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	1991	82
Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignancies Martin C. Bird, Andrew G. Bosanquet, Susan Forskitt, Leukemia Research Hematological MalignancyHealth SciencesMedicineMalignant Blood DisorderHematology	1986	54
Enhanced Ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology Andrew G. Bosanquet, Philip B. Bell Leukemia Research Immunocytochemical TechniqueImmunologyImmunophenotypingImmunotherapyHematological Malignancy	1996	44
An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia Andrew G. Bosanquet, M. C. Bird, William J. Price, British Journal of Cancer Hematological MalignancyTumor BiologyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicine	1983	43
Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on <i>ex vivo</i> drug response by DiSC assay Andrew G. Bosanquet, Stephen A. Johnson, Sue Richards British Journal of Haematology	1999	39
Long-term comparison of results of a drug sensitivity assayin vitro with patient response in lymphatic neoplasms Martin C. Bird, Andrew G. Bosanquet, Susan Forskitt, Cancer ImmunologyPathologyPharmacotherapyMetronomic ChemotherapyImmunotherapy	1988	38
Stability of Melphalan Solutions During Preparation and Storage Andrew G. Bosanquet Journal of Pharmaceutical Sciences Food PreservationMelphalan SolutionsFood ProcessingEdible Packaging	1985	37

Page 1